Remove tag emerging-pharma
article thumbnail

RFID: The future of smart labelling?

Pharmaceutical Technology

The pharmaceutical industry began using radio frequency identification (RFID) tags in the early 2000s. Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. Twenty years ago, the cost of implementing RFID tags and the ecosystem (software) was much more expensive than today.

article thumbnail

Apellis set to take on Alexion as FDA clears PNH drug Empaveli

pharmaphorum

Apellis Pharma has secured FDA approval for its complement C3 inhibitor Empaveli as a treatment for paroxysmal nocturnal hemoglobinuria (PNH) – with a label that will allow it to challenge Alexion’s established therapies directly. .

Drugs 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A history of Pfizer

pharmaphorum

Few companies embody the term ‘pharma giant’ as much as Pfizer. After the war, Pfizer continued to focus on industrial chemicals as much as medicines, producing the citric acid needed for the emerging soft drinks industry, fuelling brands like Coca Cola and Dr Pepper’s expansion in the 1880s. The era of mega-mergers.

Sales 127
article thumbnail

Sanofi offers refunds for Cablivi in novel model for rebates

Pharmaceutical Technology

The program follows the lead of Pfizer’s warranty programs for Panzyga (immune globulin intravenous) and Xalkori (crizotinib), as pharma continues to explore new types of risk sharing agreements. With these therapies, there is the possibility of there being no clinical benefit and an emergence of adverse events.

article thumbnail

The Covid cash cow – a look at the Covid vaccine sales figures

pharmaphorum

Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. billion, with more than $500 million coming from Europe and $455 million from emerging markets. The market potential for any vaccine currently in trials is lower because the only markets really are the developing countries, which can’t pay the same prices.”.

Sales 132
article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

Following this, Rebecca Croasdale-Wood, PhD, Director, Augmented Biologics Discovery & Design, Biologics Engineering, Oncology, AstraZeneca, will present: ‘Benchmarking the impact of AI biologics discovery and optimisation for pharma’. Croasdale-Wood will then participate in a keynote chat, interviewed by Miho.

article thumbnail

A history of Johnson & Johnson

pharmaphorum

By most measures the single largest pharma company in the world, US-based Johnson & Johnson (J&J) is also arguably one of the most well-known drugmakers among the general public. . As with most of the pharma industry, J&J’s financials were hit by COVID uncertainty in 2020, the impacts of which may be felt for years to come.

Sales 119